跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bortesum - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bortesum
Approved
STANDARD
Bortesum
Sun Pharmaceutical Industries Ltd., India
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d99a6f13de8b6628
Company
Sun Pharmaceutical Industries Ltd., India
Type
Standard
Approval Details
Approval Id
d99a6f13de8b6628
Drug Approval Philippines Name
Bortesum
Product Name
Bortesum
Registration Number
DRP-8735
Brand Name
Bortesum
Generic Name
Bortezomib
Dosage Form
Lyophilized Powder For Injection (Iv/Sc)
Dosage Strength
3.5 mg/VIAL
Manufacturer
Sun Pharmaceutical Industries Ltd., India
Importer
Sun Pharma Philippines Inc.
Distributor
Sun Pharma Philippines Inc.
Issuance Date
27 April 2022
Expiry Date
03 October 2027
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d99a6f13de8b6628
Type
Standard
Back to Philippines FDA Approvals